222 related articles for article (PubMed ID: 1891714)
1. Rel-associated pp40: an inhibitor of the rel family of transcription factors.
Davis N; Ghosh S; Simmons DL; Tempst P; Liou HC; Baltimore D; Bose HR
Science; 1991 Sep; 253(5025):1268-71. PubMed ID: 1891714
[TBL] [Abstract][Full Text] [Related]
2. Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity.
Inoue J; Kerr LD; Rashid D; Davis N; Bose HR; Verma IM
Proc Natl Acad Sci U S A; 1992 May; 89(10):4333-7. PubMed ID: 1533932
[TBL] [Abstract][Full Text] [Related]
3. The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation.
Kerr LD; Inoue J; Davis N; Link E; Baeuerle PA; Bose HR; Verma IM
Genes Dev; 1991 Aug; 5(8):1464-76. PubMed ID: 1907941
[TBL] [Abstract][Full Text] [Related]
4. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
Ganchi PA; Sun SC; Greene WC; Ballard DW
Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333
[TBL] [Abstract][Full Text] [Related]
5. I-Rel: a novel rel-related protein that inhibits NF-kappa B transcriptional activity.
Ruben SM; Klement JF; Coleman TA; Maher M; Chen CH; Rosen CA
Genes Dev; 1992 May; 6(5):745-60. PubMed ID: 1577270
[TBL] [Abstract][Full Text] [Related]
6. A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site.
Bours V; Burd PR; Brown K; Villalobos J; Park S; Ryseck RP; Bravo R; Kelly K; Siebenlist U
Mol Cell Biol; 1992 Feb; 12(2):685-95. PubMed ID: 1531086
[TBL] [Abstract][Full Text] [Related]
7. Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal.
Ghosh S; Gifford AM; Riviere LR; Tempst P; Nolan GP; Baltimore D
Cell; 1990 Sep; 62(5):1019-29. PubMed ID: 2203532
[TBL] [Abstract][Full Text] [Related]
8. The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function.
Ballard DW; Walker WH; Doerre S; Sista P; Molitor JA; Dixon EP; Peffer NJ; Hannink M; Greene WC
Cell; 1990 Nov; 63(4):803-14. PubMed ID: 2225078
[TBL] [Abstract][Full Text] [Related]
9. Rapid induction in regenerating liver of RL/IF-1 (an I kappa B that inhibits NF-kappa B, RelB-p50, and c-Rel-p50) and PHF, a novel kappa B site-binding complex.
Tewari M; Dobrzanski P; Mohn KL; Cressman DE; Hsu JC; Bravo R; Taub R
Mol Cell Biol; 1992 Jun; 12(6):2898-908. PubMed ID: 1588976
[TBL] [Abstract][Full Text] [Related]
10. DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide.
Nolan GP; Ghosh S; Liou HC; Tempst P; Baltimore D
Cell; 1991 Mar; 64(5):961-9. PubMed ID: 2001591
[TBL] [Abstract][Full Text] [Related]
11. Bcl-3, a member of the I kappa B proteins, has distinct specificity towards the Rel family of proteins.
Inoue J; Takahara T; Akizawa T; Hino O
Oncogene; 1993 Aug; 8(8):2067-73. PubMed ID: 8336935
[TBL] [Abstract][Full Text] [Related]
12. The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation.
Walker WH; Stein B; Ganchi PA; Hoffman JA; Kaufman PA; Ballard DW; Hannink M; Greene WC
J Virol; 1992 Aug; 66(8):5018-29. PubMed ID: 1321284
[TBL] [Abstract][Full Text] [Related]
13. Heterologous C-terminal sequences disrupt transcriptional activation and oncogenesis by p59v-rel.
Diehl JA; Hannink M
J Virol; 1993 Dec; 67(12):7161-71. PubMed ID: 8230438
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the rel-homology domain alter the biochemical properties of v-rel and render it transformation defective in chicken embryo fibroblasts.
Morrison LE; Boehmelt G; Enrietto PJ
Oncogene; 1992 Jun; 7(6):1137-47. PubMed ID: 1594245
[TBL] [Abstract][Full Text] [Related]
15. Transformation of avian fibroblasts overexpressing the c-rel proto-oncogene and a variant of c-rel lacking 40 C-terminal amino acids.
Kralova J; Schatzle JD; Bargmann W; Bose HR
J Virol; 1994 Apr; 68(4):2073-83. PubMed ID: 8138992
[TBL] [Abstract][Full Text] [Related]
16. The activity of a 70 kilodalton I kappa B molecule identical to the carboxyl terminus of the p105 NF-kappa B precursor is modulated by protein kinase A.
Gerondakis S; Morrice N; Richardson IB; Wettenhall R; Fecondo J; Grumont RJ
Cell Growth Differ; 1993 Aug; 4(8):617-27. PubMed ID: 8398903
[TBL] [Abstract][Full Text] [Related]
17. The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product.
Kieran M; Blank V; Logeat F; Vandekerckhove J; Lottspeich F; Le Bail O; Urban MB; Kourilsky P; Baeuerle PA; Israël A
Cell; 1990 Sep; 62(5):1007-18. PubMed ID: 2203531
[TBL] [Abstract][Full Text] [Related]
18. Interaction of the v-rel protein with an NF-kappa B DNA binding site.
Kabrun N; Hodgson JW; Doemer M; Mak G; Franza BR; Enrietto PJ
Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1783-7. PubMed ID: 1848011
[TBL] [Abstract][Full Text] [Related]
19. RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.
Ryseck RP; Bull P; Takamiya M; Bours V; Siebenlist U; Dobrzanski P; Bravo R
Mol Cell Biol; 1992 Feb; 12(2):674-84. PubMed ID: 1732739
[TBL] [Abstract][Full Text] [Related]
20. PEST-dependent cytoplasmic retention of v-Rel by I(kappa)B-alpha: evidence that I(kappa)B-alpha regulates cellular localization of c-Rel and v-Rel by distinct mechanisms.
Rottjakob EM; Sachdev S; Leanna CA; McKinsey TA; Hannink M
J Virol; 1996 May; 70(5):3176-88. PubMed ID: 8627798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
